Additionally, this study investigated the correlations between anxiety, depression, sleep disturbances, self-efficacy, and PRL levels in prolactinoma patients, thus providing evidence for targeted interventions to improve the quality of life and psychological status of prolactinoma patients. This evidence concerns the gene PRL and depressive disorder.